Diagnosis and assessment of premenstrual dysphoria

Psychiatric Annals

Volumn 26, Issue 9, 1996, Pages 571-575

  Steiner, Meir ^a   Wilkins, Annette ^a  

^a ST JOSEPH S HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 6244282310     PISSN: 00485713     EISSN: None     Source Type: Journal    
DOI: 10.3928/0048-5713-19960901-09     Document Type: Article

References (44)

1. Diagnostic and Statistical Manual of Mental Disorders. 3rd ed rev. Washington, DC: American Psychiatric Association; 1987:367-369.
2. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: American Psychiatric Association; 1994:717-718.
3. World Health Organization. Mental, Behavioral and Developmental Disorders. 10th revision of the International Classification of Diseases (1986 draft for field trials). Geneva, Switzerland: WHO; 1987.
4. Rubinow DR, Schmidt PJ. Models for the development and expression of symptoms in premenstrual syndrome. Psychiatr Clin North Am. 1989; 12:53-68.
5. Johnson SR. The epidemiology and social impact of premenstrual symptoms. Clin Obstet Gynecol. 1987; 30:367-376.
6. Haskett RF, De Longis A, Kessler RC. Premenstrual dysphoria: a community survey. Presented at the Annual American Psychiatric Association Meeting; Chicago, Illinois; May 9-15, 1987.
7. Johnson SR, McChesney C, Bean JA. Epidemiology of premenstrual symptoms in a nonclinical sample, I: prevalence, natural history and help-seeking behaviour. J Reprod Med. 1988; 33:340-346.
8. Rivera-Tovar AD, Frank E. Late luteal phase dysphoric disorder in young women. Am J Psychiatry. 1990; 147:1634-1636.
9. Andersch B, Wendestam C, Hahn L, Ohman R. Premenstrual complaints, I: prevalence of premenstrual symptoms in a Swedish urban population. J Psychosom Obstet Gynaecol. 1986; 5:39-49.
10. Merikangas KR, Foeldenyi M, Angst J. The Zurich Study. XIX. Patterns of menstrual disturbances in the community: results of the Zurich Cohort Study. Eur Arch Psychiatry Clin Neurosci. 1993; 243:23-32.
11. Ramacharan S, Love EJ, Fick GH, Goldfien A. The epidemiology of premenstrual symptoms in a population based sample of 2650 urban women. J Clin Epidemiol. 1992; 45:377-392.
12. Freeman EW, Sondheimer K, Weinbaum PH, et al. Evaluating premenstrual symptoms in medical practice. Obstet Gynecol. 1985; 65:500-505.
13. O'Brien PMS, Abukhalil IEH, Henshaw C. Premenstrual syndrome. Curr Obstet Gynecol. 1995; 5:30-37.
14. Budeiri DJ, LiWanPo A, Dornan JC. Clinical trials of treatment of premenstrual syndrome: entry criteria and scales for measuring treatment outcomes. Br J Obstet Gynecol. 1994; 101:689-695.
15. Schnurr PP, Hurt SW, Stout AL. Consequences of methodological decisions in the diagnosis of late luteal phase dyphoric disorder. In: Gold JH, Severino SK, eds. Premenstrual Dysphorias: Myths and Realities. Washington, DC: American Psychiatric Press, Inc; 1994:715-718.
16. Haskett RF, Steiner M, Osmun JN, Carroll BJ. Severe premenstrual tension: delineation of the syndrome. Biol Psychiatry. 1980; 15:121-139.
17. Endicott J, Harrison W. The daily record of severity of problems. Available from Dr Endicott, New York State Psychiatric Institute, Biometrics Unit, 722 West 168th St, New York, NY 10032.
18. Yonkers KA, Gullion C, Williams A, Novak K, Rush AJ. Paroxetine as a treatment for premenstrual disorder. J Clin Psychopharmacol. 1996; 16:3-8.
19. Sundblad C, Modigh K, Andersch B, Eriksson E. Clomipramine effectively reduces premenstrual irritability and dysphoria: a placebo controlled trial. Acta Psychiatr Scand. 1992; 85:39-47.
20. Hahn PM, Van Vugt DA, Reid RL. A randomized, placebo-controlled crossover trial of danazol for the treatment of premenstrual syndrome. Psychoneuroendocrinology. 1995; 20:193-209.
21. Schmidt PJ, Grover GN, Rubinow DR. Alpralazom in the treatment of premenstrual treatment: a double-blind, placebo-controlled trial. Arch Gen Psychiatry. 1993; 50:467-473.
22. Steiner M, Steinberg S, Stewart D, et al. Fluoxetine in the treatment of premenstrual dysphoria. N Engl J Med. 1995; 332:1529-1534.
23. Casper RF, Powell AM. Premenstrual syndrome: documentation by a linear analogue scale compared with two descriptive scales. Am J Obstet Gynecol. 1986; 155:862-867.
24. Steiner M, Haskett RF, Carroll BJ. Premenstrual tension syndrome: the development of research diagnostic criteria and new rating scales. Acta Psychiatr Scand. 1980; 62:177-190.
25. Moos RH. The development of a menstrual distress questionnaire. Psychosom Med. 1968; 30:853-867.
26. Muse KN, Cetel NS, Futterman LA, Yen SSC. The premenstrual syndrome: effects of "medical ovariectomy." N Engl J Med. 1984; 311:1345-1349.
27. Smith S, Rinehart JS, Ruddock VE, Schiff I. Treatment of premenstrual syndrome with alpralazom: results of a double-blind, placebo-controlled randomized crossover clinical trial. Obstet Gynecol. 1987; 70:37-43.
28. Maddocks S, Hahn P, Moller F, Reid RL. A double-blind placebo-controlled trial of progesterone vaginal suppositories in the treatment of premenstrual syndrome. Am J Obstet Gynecol. 1986; 154:573-581.
29. Su TP, Schmidt PJ, Danaceau, et al. Fluoxetine in the treatment of premenstrual syndrome. Neuropsychopharmacology. 1996. In press.
30. Condon JT. The premenstrual syndrome: a twin study. Br J Psychiatry. 1993; 162:481-486.
31. Halbreich U, Endicott J. The relationship of dysphoric premenstrual changes to depressive disorder. Acta Psychiatr Scand. 1985; 71:331-338.
32. Harrison WM, Endicott J, Nee J, et al. Characteristics of women seeking treatment for premenstrual syndrome. Psychosomatics. 1989; 30:405-411.
33. Fava M, Pedrazzi F, Guaraldi GP, et al. Comorbid anxiety and depression among patients with late luteal phase dysphoric disorder. J Anxiety Disord. 1992; 6:325-335.
34. McLeod DR, Hoehn-Saric R, Foster GV, Hipsley PA. The influence of premenstrual syndrome on ratings of anxiety in women with generalized anxiety disorder. Acta Psychiatr Scand. 1993; 88:248-251.
35. Endicott J. The menstrual cycle and mood disorders. J Affect Disord. 1993; 29:193-200.
36. Bancroft J, Rennie D, Warner P. Vulnerability to perimenstrual mood change: the relevance of a past history of depressive disorder. Psychosom Med. 1994; 56:225-234.
37. Kaspi SP, Otto MW, Pollack MH, et al. Premenstrual exacerbation of symptoms in women with panic disorder. J Anxiety Disord. 1994; 8:131-138.
38. Graze KK, Nee J, Endicott J. Premenstrual depression predicts future major depressive disorder. Acta Psychiatr Scand. 1990; 81:201-206.
39. Reid RL. Premenstrual syndrome. Curr Probl Obstet Gynecol Fertil. 1985; 8:1-57.
40. Mortola JF, Girton L, Beck L, Yen SSC. Diagnosis of premenstrual syndrome by a simple, prospective, and reliable instrument: the calendar of premenstrual experiences. Obstet Gynecol. 1990; 76:302-307.
41. National Institute of Mental Health. NIMH Premenstrual Syndrome Workshop Guidelines; April 14-15, 1983; Rockville, Md: National Institute of Mental Health.
42. Guy W. ECDEU assessment of manual for psychopharmacology. NIMH publication Department of Health, Education, and Human Welfare Publication No. (Adm.) 76-338 (Revised). Rockville, Md; 1976:217-222.
43. Freeman EW, Schweizer E, Rickels K. Personality factors in women with premenstrual syndrome. Psychosom Med. 1995; 57:453-459.
44. Kendler KS, Silberg JL, Neale MC, et al. Genetic and environmental factors in the aetiology of menstrual, premenstrual and neurotic symptoms: a population-based twin study. Psychol Med. 1992; 22:1-16.